Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 4

Effects of an Additional Liquid Based Cytology Prepate on Cytological Diagnosis in High-Risk HPV Positive, PaP Test Negative Cases

Pages
361–365
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With this protocol, patient management changes,follow-up time and number can be reduced.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate the effects of a second cytology preparation on cytological diagnosis in high-risk HPV positive and PaPsmear-negative cases.Methods: This retrospective study was conducted with 57 cases who underwent cytological evaluation and cotest in our centerin 2016-2017.
📊
Key Findings & Data:Twenty-five of the cases who had a positive diagnosis in the secondpreparation had a cervical biopsy.Results: In 46 (80%) of the cases, the cytological diagnosis was the same and negative in the first and second preparations.
💡
Conclusion & Impact:With this protocol, patient management changes,follow-up time and number can be reduced.
🔬Design:Research Article
📍Scope:2016-2017 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: To investigate the effects of a second cytology preparation on cytological diagnosis in high-risk HPV positive and PaPsmear-negative cases.Methods: This retrospective study was conducted with 57 cases who underwent cytological evaluation and cotest in our centerin 2016-2017. All of these cases were high-risk HPV positive, PaP smear-negative and had a second preparation. All preparationswere re-evaluated by a cytopathologist and a pathologist. Twenty-five of the cases who had a positive diagnosis in the secondpreparation had a cervical biopsy.Results: In 46 (80%) of the cases, the cytological diagnosis was the same and negative in the first and second preparations. Secondpreparations of 11 cases (19.2%) were positive. Twenty of 25 patients (77%) with cervical biopsy had premalignant lesion.Conclusion: In high-risk HPV positive and PaP smear-negative cases, patient management is different from cases where these twotests are positive together. According to our results, 19.2% of high-risk HPV positive and PaP smear-negative cases were given positive cytological diagnosis by second cytology preparation. Biopsy results support our cytological findings. The incidence of positive cytological diagnosis increases in PaP smear with the second preparation. With this protocol, patient management changes,follow-up time and number can be reduced.

🔖

Cite This Article

ŞAHİN, D., KOÇ, N., AKBAŞ, M. (2019). Effects of an Additional Liquid Based Cytology Prepate on Cytological Diagnosis in High-Risk HPV Positive, PaP Test Negative Cases. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 4, 361–365. https://ajindex.com/articles/363421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Doğan O, Pulatoğlu Ç, Başbuğ A, Kaya AE, Yassa M. Discriminating Performance of Early Uterine and Cervical Artery Pulsatility and Resistivity In Pre-Invasive Cervical Lesions. Med Bull Sisli Etfal Hosp 2018;52:206–11
  2. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, et al. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 2006;7:529–32
  3. Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, et al. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results. J Clin Microbiol 2015;53:52–9
  4. Carozzi F, Ronco G, Confortini M, Noferini D, Maddau C, Ciatto S, et al. Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer 2000;83:1462–7
  5. Petry KU, Rinnau F, Böhmer G, Hollwitz B, Luyten A, Buttmann N, et al. Annual Papanicolaou screening for 5 years among human papillomavirus-negative women. BMC Cancer 2013;13:379
  6. Kinney W, Fetterman B, Cox JT, Lorey T, Flanagan T, Castle PE. Characteristics of 44 cervical cancers diagnosed following Papnegative, high risk HPV-positive screening in routine clinical practice. Gynecol Oncol 2011;121:309–13
  7. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516–42
  8. Jeong H, Hong SR, Chae SW, Jin SY, Yoon HK, Lee J, et al. Comparison of Unsatisfactory Samples from Conventional Smear versus Liquid-Based Cytology in Uterine Cervical Cancer Screening Test. J Pathol Transl Med 2017;51:314–9
  9. Massarani-Wafai R, Bakhos R, Wojcik EM, Selvaggi SM. Evaluation of cellular residue in the ThinPrep PreservCyt vial. Diagn Cytopathol 2000;23:208–12
  10. Ritu N, Wilbur D. C. The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria and Explanatory Notes. 3nd ed. New York: Springer; 2014. p. xii–xv
  11. Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155:687–97
  12. Grapsa D, Ioakim-Liossi A, Stergiou E, Petrakakou E, Nicolopou